A Phase 2 study of Brentuximab Vedotin plus Nivolumab without Stem Cell Consolidation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
ENROLLING
Trial ID:
NCT04561206 Protocol # :
22-121
Phase
II
Disease Sites
Hodgkin's Lymphoma
Principal Investigator
Armand, Philippe
Site Research Nurses
Aiken, Haley
Aiken, Haley
Chung, Anita
Maciejewski, Ashley, Taylor
Smith, Caitlin
Tichon, Jennifer
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-121
22-121